Therapeutic doses of ACTH given daily and maintained for more than 2 years in patients with polyarthritis do not normally suppress hypothalamicpituitary-adrenal (HPA) responsiveness to the stresses of insulin hypoglycaemia or surgery (Carter and James, 1970a, b) . By contrast, corticosteroids in daily doses equivalent to 7 5 mg. or more of prednisolone will impair pituitary-adrenal function in most patients, but our attempts to mitigate their suppressive effect by combining steroid treatment with intermittent ACTH in reasonable therapeutic dosage were unsuccessful (Carter and James, 1970c) . In fact, pituitary-adrenal suppression as judged by response to insulin-induced hypoglycaemia appeared to be increased rather than offset. Thus it seemed that the administration of therapeutic daily doses of steroids inevitably causes suppression.
Using a daily administration schedule, this suppression can be diminished by single as opposed to divided daily doses of steroid (Myles, Bacon, and Daly, 1971) . In recent years, too, physicians treating patients with other chronic diseases, such as the nephrotic syndrome, ulcerative colitis, asthma, and sarcoidosis, in which much larger maintenance doses ofcorticosteroids tend to be used, have been exploring intermittent regimes with a view to diminishing some of the side-effects, including Cushingoid features, growth inhibition in children, osteoporosis, and impairment of HPA function, without loss of therapeutic effect (Soyka and Saxena, 1965; Ackerman and Nolan, 1968; Sadeghi-Nejad and Senior, 1969) .
The most promising administration schedule appeared to be by a single dose once every 48 hours, and it seemed important to us to try to establish whether this method of steroid administration, Accepted for publication January 6, 1972. especially as applied to the relatively small maintenance doses employed in the management of rheumatoid disease, would be therapeutically practicable, and would preserve the integrity of the HPA axis; this report relates our experience with such a regime in patients with active chronic polyarthritis.
Material and methods
Of fourteen patients studied, twelve women and two men, ten were suffering from active classical rheumatoid arthritis, according to the A.R.A. criteria (Ropes, Bennett, Cobb, Jacox, and Jessar, 1958) , two from probable rheumatoid arthritis, and two from psoriatic arthropathy. Their mean age is 48 years (range 15 to 73) and the mean duration from onset of disease is 8 years (range 1 to 18).
Only patients who were considered to require 10 mg. or more of prednisolone daily were included, and they were given the sum of their 48 hour four-times-a-day steroid requirement as a single dose after breakfast every other day. Seven patients (Group 1) who had not received steroids previously were started on the alternate-day steroid regime: two of these patients (S.S. and M.W.) had received daily ACTH injections before starting steroids. Seven patients (Group II) were transferred to the alternate-day single-dose regime from treatment with daily divided doses ofsteroids, or from steroids and ACIH in some combination used in our earlier studies. All patients were receiving a maintenance dose of entericcoated aspirin 4 to 6 g. daily, and in an attempt to spare them any see-sawing effect of symptoms between steroid doses, they were instructed to take 100mg. phenylbutazone three times a day on the non-steroid days.
As in our previous studies, pituitary-adrenal function was tested by insulin induced hypoglycaemia as described elsewhere (Greenwood, Landon, and Stamp, 1966 (Townsend and James, 1968) . The corticosteroid used was enteric-coated prednisolone "DeltaCortril" (Pfizer) . Phenylbutazone was given as Butazolidin Alka (Geigy) in the hope of minimizing the dyspeptic and haemorrhagic risk with a combination of three potentially gastro-irritant drugs, and was found to be very well tolerated. No serious dyspepsia was encountered, and no frank bleeding episodes occurred.
Results
Figs 1 and 2 show the results of serial insulin stress tests performed on the patients in the two groups, i.e. those starting on steroids for the first time and those whose treatment has been converted from daily divided doses of steroids (sometimes in combination with ACTH) to the alternate-day regime. The graphs for each patient show the increment of plasma cortisol in utg./100 ml., from the resting level to the (Soyka and Saxena, 1967) and others have used metyrapone (Fleisher, 1967) or insulin hypoglycaemia (Ackerman and Nolan, 1968 (Fig. 3) . It is nevertheless of considerable interest that one patient receiving alternate-day steroids showed an excellent response to hypoglycaemia when tested at 5 weeks, whilst 4 weeks later almost complete suppression had occurred. (Fig. 2) . They all showed improvement in their test responses, but the time taken for this recovery varied from 2 weeks to several months. This recovery period was not apparently related to the total dosage or to the duration of the daily dosage of previous steroid treatment.
Our data also reveal that there may be considerable variations in response whilst treatment is maintained unaltered (e.g. patient E.H., Fig. 2 ). This individual variability has also been observed in our investigations of patients receiving continuous daily corticotrophin therapy (Carter and James, 1970a) .
One obvious explanation for such variation could be irregularity of adherence to the prescribed regime.
As far as it is possible to be certain, we have complete confidence that all the patients concerned were entirely conscientious throughout the study. A small number who reported failure for various good reasons were excluded because of an inadequate follow-up period.
Using this method of administration, there are steep rises in plasma prednisolone levels once every 48 hours, and we are not in a position to assess the effect of this on any parameter other than pituitaryadrenal stress responsiveness. It is open to speculation whether this regime is associated with other advantages, or whether it may incur some disadvantages. Ackerman and Nolan (1968) , Soyka and Saxena (1965) , and Soyka (1967) have indicated that, when much larger doses of steroids are administered in this way to patients with other diseases such as the nephrotic syndrome, there is a diminution of certain other side-effects-notably the Cushingoid appearance and the inhibition of growth in juveniles.
Preservation of pituitary-adrenal function by this regime would be of purely academic interest if therapeutic efficacy was impaired, and some mention of our clinical experience is therefore important. We have been able to study relatively few patients, but the period of maintenance in some of them is now over 2 years, and we have the advantage that all patients are seen regularly and assessed by one physician to whom they are well known.
Some difficulties were encountered: two patients, both ofwhom could tolerate divided doses ofsteroids, were unable to tolerate 20 or 25 mg. prednisolone in one dose taken after food, as instructed. They experienced severe dyspepsia, giddiness, and faintness and had to lie down for the rest of the day. One very conscientious patient was worried especially about this, because she was unable to perform her daily exercises without which she could not maintain her muscle strength and mobility. Both patients renewed attempts to take this dose, but were unable to continue. This was surprising in view of the much larger single doses (up to 120 mg.) that some patients take as treatment for other diseases.
Several patients whose treatment was converted from daily steroids experienced intolerable rheumatoid symptoms of pain and stiffness when the regime was altered. The majority, however, whom it must be emphasized were carefully selected for this pilot study for their stability of temperament and their stoical and sensible attitude to their disease, managed very well. The rationale for choosing this regime was explained and their full co-operation was ensured.
They were advised to mark on a card calendar the days on which they had taken the steroids, and they were given instructions for dealing with 
